市場調查報告書

抗青光眼藥的全球市場的預測

Antiglaucoma Drugs Global Market Report 2020

出版商 The Business Research Company 商品編碼 915206
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
抗青光眼藥的全球市場的預測 Antiglaucoma Drugs Global Market Report 2020
出版日期: 2019年11月01日內容資訊: 英文
簡介

本報告提供全球抗青光眼藥市場相關調查分析,市場特徵、規模、成長率,區分,各地區、各國明細,競爭情形,市場佔有率,趨勢、策略相關的系統性資訊。

第1章 摘要整理

第2章 抗青光眼藥市場特徵

第3章 抗青光眼藥市場規模、成長率

  • 市場成果 (金額)
  • 市場預測 (金額)

第4章 抗青光眼藥市場區隔

  • 各產品類型
  • 各病情類型
  • 各類型

第5章 抗青光眼藥市場各地區、各國分析

  • 各地區
  • 各國

第6章 亞太地區的抗青光眼藥市場

  • 市場概要
  • 各產品類型
  • 各病情類型

第7章 中國的抗青光眼藥市場

  • 市場概要
  • 各產品類型
  • 各病情類型

第8章 印度的抗青光眼藥市場

  • 市場概要
  • 各產品類型
  • 各病情類型

第9章 日本的抗青光眼藥市場

  • 市場概要
  • 各產品類型
  • 各病情類型

第10章 澳洲的抗青光眼藥市場

  • 市場概要
  • 各產品類型
  • 各病情類型

第11章 印尼的抗青光眼藥市場

  • 市場概要
  • 各產品類型
  • 各病情類型

第12章 韓國的抗青光眼藥市場

  • 市場概要
  • 各產品類型
  • 各病情類型

第13章 西歐的抗青光眼藥市場

第14章 英國的抗青光眼藥市場

第15章 德國的抗青光眼藥市場

第16章 法國的抗青光眼藥市場

第17章 東歐的抗青光眼藥市場

第18章 俄羅斯的抗青光眼藥市場

第19章 北美的抗青光眼藥市場

第20章 美國的抗青光眼藥市場

第21章 南美的抗青光眼藥市場

第22章 巴西的抗青光眼藥市場

第23章 中東的抗青光眼藥市場

第24章 非洲的抗青光眼藥市場

第25章 抗青光眼藥市場競爭情形和企業簡介

  • 競爭情形
  • 企業簡介

第26章 抗青光眼藥市場主要M&A

第27章 抗青光眼藥市場趨勢與策略

第28章 產品平台分析

第29章 抗青光眼藥市場未來發展預測與可能性分析

第30章 附錄

目錄

Antiglaucoma Drugs Market Global Report 2020 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the global antiglaucoma drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the antiglaucoma drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Antiglaucoma Drugs Market Global Report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market.

  • The Market Characteristics section of the report defines and explains the market.
  • The Market Size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market Segmentations break down market into sub markets.
  • The Regional and Country section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive Landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The Trends and Strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

Scope

Markets Covered: 1) By Product Type: Alpha Agonist, Beta Blockers, Prostaglandin Analogs, Combined Medication, Others 2) By Disease Condition Type: Open-Angle Glaucoma, Angle-Closure Glaucoma, Normal-Tension Glaucoma, Congenital Glaucoma, Other Types Of Glaucoma 3) By Type: Hospital Prescription drugs, Over-the counter drugs

Companies Mentioned: Aerie Pharmaceuticals, Inc., ALLERGAN, Novartis AG, Abbott Healthcare, Johnson & Johnson

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time Series: Five years historic and forecast.

Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Antiglaucoma Drugs Market Characteristics

3. Antiglaucoma Drugs Market Size And Growth

  • 3.1. Global Antiglaucoma Drugs Historic Market, 2015 - 2019, $ Billion
    • 3.1.1. Drivers Of The Market
    • 3.1.2. Restraints On The Market
  • 3.2. Global Antiglaucoma Drugs Forecast Market, 2019 - 2022F, 2025F, 2030F, $ Billion
    • 3.2.1. Drivers Of The Market
    • 3.2.2. Restraints On the Market

4. Antiglaucoma Drugs Market Segmentation

  • 4.1. Global Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Alpha Agonist
    • Beta Blockers
    • Prostaglandin Analogs
    • Combined Medication
    • Others
  • 4.2. Global Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Open-Angle Glaucoma
    • Angle-Closure Glaucoma
    • Normal-Tension Glaucoma
    • Congenital Glaucoma
    • Other Types Of Glaucoma
  • 4.3. Global Antiglaucoma Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
    • Hospital Prescription drugs
    • Over-the counter drugs

5. Antiglaucoma Drugs Market Regional And Country Analysis

  • 5.1. Global Antiglaucoma Drugs Market, Split By Region, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 5.2. Global Antiglaucoma Drugs Market, Split By Country, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

6. Asia-Pacific Antiglaucoma Drugs Market

  • 6.1. Asia-Pacific Antiglaucoma Drugs Market Overview
  • 6.2. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 6.3. Asia-Pacific Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

7. China Antiglaucoma Drugs Market

  • 7.1. China Antiglaucoma Drugs Market Overview
  • 7.2. China Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion
  • 7.3. China Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F,$ Billion

8. India Antiglaucoma Drugs Market

  • 8.1. India Antiglaucoma Drugs Market Overview
  • 8.2. India Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 8.3. India Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

9. Japan Antiglaucoma Drugs Market

  • 9.1. Japan Antiglaucoma Drugs Market Overview
  • 9.2. Japan Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 9.3. Japan Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

10. Australia Antiglaucoma Drugs Market

  • 10.1. Australia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 10.2. Australia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

11. Indonesia Antiglaucoma Drugs Market

  • 11.1. Indonesia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 11.2. Indonesia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

12. South Korea Antiglaucoma Drugs Market

  • 12.1. South Korea Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 12.2. South Korea Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

13. Western Europe Antiglaucoma Drugs Market

  • 13.1. Western Europe Antiglaucoma Drugs Market Overview
  • 13.2. Western Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 13.3. Western Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

14. UK Antiglaucoma Drugs Market

  • 14.1. UK Antiglaucoma Drugs Market Overview
  • 14.2. UK Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 14.3. UK Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

15. Germany Antiglaucoma Drugs Market

  • 15.1. Germany Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 15.2. Germany Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

16. France Antiglaucoma Drugs Market

  • 16.4. France Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 16.5. France Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

17. Eastern Europe Antiglaucoma Drugs Market

  • 17.1. Eastern Europe Antiglaucoma Drugs Market Overview
  • 17.2. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 17.3. Eastern Europe Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

18. Russia Antiglaucoma Drugs Market

  • 18.1. Russia Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 18.2. Russia Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

19. North America Antiglaucoma Drugs Market

  • 19.1. North America Antiglaucoma Drugs Market Overview
  • 19.2. North America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 19.3. North America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

20. USA Antiglaucoma Drugs Market

  • 20.1. USA Antiglaucoma Drugs Market Overview
  • 20.2. USA Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 20.3. USA Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

21. South America Antiglaucoma Drugs Market

  • 21.1. South America Antiglaucoma Drugs Market Overview
  • 21.2. South America Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 21.3. South America Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

22. Brazil Antiglaucoma Drugs Market

  • 22.1. Brazil Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 22.2. Brazil Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

23. Middle East Antiglaucoma Drugs Market

  • 23.1. Middle East Antiglaucoma Drugs Market Overview
  • 23.2. Middle East Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 23.3. Middle East Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

24. Africa Antiglaucoma Drugs Market

  • 24.1. Africa Antiglaucoma Drugs Market Overview
  • 24.2. Africa Antiglaucoma Drugs Market, Segmentation By Product Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion
  • 24.3. Africa Antiglaucoma Drugs Market, Segmentation By Disease Condition Type, Historic and Forecast, 2015-2019, 2022F, 2025F, 2030F, $ Billion

25. Antiglaucoma Drugs Market Competitive Landscape And Company Profiles

  • 25.1. Antiglaucoma Drugs Market Competitive Landscape
  • 25.2. Antiglaucoma Drugs Market Company Profiles
    • 25.2.1. Aerie Pharmaceuticals, Inc
      • 25.2.1.1. Overview
      • 25.2.1.2. Products and Services
      • 25.2.1.3. Strategy
      • 25.2.1.4. Financial Performance
    • 25.2.2. ALLERGAN
      • 25.2.2.1. Overview
      • 25.2.2.2. Products and Services
      • 25.2.2.3. Strategy
      • 25.2.2.4. Financial Performance
    • 25.2.3. Novartis AG
      • 25.2.3.1. Overview
      • 25.2.3.2. Products and Services
      • 25.2.3.3. Strategy
      • 25.2.3.4. Financial Performance
    • 25.2.4. Abbott Healthcare
      • 25.2.4.1. Overview
      • 25.2.4.2. Products and Services
      • 25.2.4.3. Strategy
      • 25.2.4.4. Financial Performance
    • 25.2.5. Johnson & Johnson
      • 25.2.5.1. Overview
      • 25.2.5.2. Products and Services
      • 25.2.5.3. Strategy
      • 25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Antiglaucoma Drugs Market

27. Antiglaucoma Drugs Market Trends And Strategies

28. Product Pipeline Analysis

29. Antiglaucoma Drugs Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top